当前位置: 首页 > 详情页

Differentiation of neuropsychological features between posterior cortical atrophy and early onset Alzheimer's disease

文献详情

资源类型:
WOS体系:

收录情况: ◇ SCIE

机构: [1]Innovation Center for Neurological Disorders, Department of Neurology, Xuan Wu Hospital, Capital Medical University, Beijing, People’s Republic of China. [2]Beijing Key Laboratory of Geriatric Cognitive Disorders, Beijing, People’s Republic of China. [3]Clinical Center for Neurodegenerative Disease and Memory Impairment, Capital Medical University, Beijing, People’s Republic of China. [4]Center of Alzheimer’s Disease, Beijing Institute for Brain Disorders, Beijing, People’s Republic of China. [5]Key Laboratory of Neurodegenerative Diseases, Ministry of Education, Beijing, People’s Republic of China. [6]National Clinical Research Center for Geriatric Disorders, Beijing, People’s Republic of China. [7]The Second People’s Hospital of Guiyang, Guizhou, People’s Republic of China.
出处:
ISSN:

关键词: Posterior cortical atrophy Early onset Alzheimer's disease Cognition Neuropsychology

摘要:
Background: Posterior cortical atrophy (PCA) is a group of clinical syndromes characterized by visuospatial and visuoperceptual impairment, with memory relatively preserved. Although PCA is pathologically almost identical to Alzheimer's disease (AD), they have different cognitive features. Those differences have only rarely been reported in any Chinese population. The purpose of the study is to establish neuropsychological tests that distinguish the clinical features of PCA from early onset AD (EOAD). Methods: Twenty-one PCA patients, 20 EOAD patients, and 20 healthy controls participated in this study. Patients had disease duration of <= 4 years. All participants completed a series of neuropsychological tests to evaluate their visuospatial, visuoperceptual, visuo-constructive, language, executive function, memory, calculation, writing, and reading abilities. The cognitive features of PCA and EOAD were compared. Results: All the neuropsychological test scores showed that both the PCA and EOAD patients were significantly more impaired than people in the control group. However, PCA patients were significantly more impaired than EOAD patients in visuospatial, visuoperceptual, and visuo-constructive function, as well as in handwriting, and reading Chinese characters. Conclusions: The profile of neuropsychological test results highlights cognitive features that differ between PCA and EOAD. One surprising result is that the two syndromes could be distinguished by patients' ability to read and write Chinese characters. Tests based on these characteristics could therefore form a brief PCA neuropsychological examination that would improve the diagnosis of PCA.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2017]版:
大类 | 4 区 医学
小类 | 4 区 临床神经病学
最新[2025]版:
大类 | 3 区 医学
小类 | 4 区 临床神经病学
JCR分区:
出版当年[2016]版:
Q3 CLINICAL NEUROLOGY
最新[2023]版:
Q3 CLINICAL NEUROLOGY

影响因子: 最新[2023版] 最新五年平均 出版当年[2016版] 出版当年五年平均 出版前一年[2015版] 出版后一年[2017版]

第一作者:
第一作者机构: [1]Innovation Center for Neurological Disorders, Department of Neurology, Xuan Wu Hospital, Capital Medical University, Beijing, People’s Republic of China. [7]The Second People’s Hospital of Guiyang, Guizhou, People’s Republic of China.
通讯作者:
通讯机构: [1]Innovation Center for Neurological Disorders, Department of Neurology, Xuan Wu Hospital, Capital Medical University, Beijing, People’s Republic of China. [2]Beijing Key Laboratory of Geriatric Cognitive Disorders, Beijing, People’s Republic of China. [3]Clinical Center for Neurodegenerative Disease and Memory Impairment, Capital Medical University, Beijing, People’s Republic of China. [4]Center of Alzheimer’s Disease, Beijing Institute for Brain Disorders, Beijing, People’s Republic of China. [5]Key Laboratory of Neurodegenerative Diseases, Ministry of Education, Beijing, People’s Republic of China. [6]National Clinical Research Center for Geriatric Disorders, Beijing, People’s Republic of China.
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:17319 今日访问量:0 总访问量:932 更新日期:2025-06-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学宣武医院 技术支持:重庆聚合科技有限公司 地址:北京市西城区长椿街45号宣武医院